Inovio Pharmaceuticals Inc
NASDAQ:INO

Watchlist Manager
Inovio Pharmaceuticals Inc Logo
Inovio Pharmaceuticals Inc
NASDAQ:INO
Watchlist
Price: 2.27 USD -4.22% Market Closed
Market Cap: 155.9m USD

Intrinsic Value

The intrinsic value of one INO stock under the Base Case scenario is 10.14 USD. Compared to the current market price of 2.27 USD, Inovio Pharmaceuticals Inc is Undervalued by 78%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

INO Intrinsic Value
10.14 USD
Undervaluation 78%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Inovio Pharmaceuticals Inc

What is Valuation History?
Ask AI Assistant
What other research platforms think about INO?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is INO valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Inovio Pharmaceuticals Inc.

Explain Valuation
Compare INO to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about INO?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Inovio Pharmaceuticals Inc

Current Assets 52.7m
Cash & Short-Term Investments 47.5m
Receivables 840.3k
Other Current Assets 4.3m
Non-Current Assets 15.5m
Long-Term Investments 3.1m
PP&E 10.4m
Other Non-Current Assets 2m
Current Liabilities 31.7m
Accounts Payable 5.5m
Accrued Liabilities 14.8m
Other Current Liabilities 11.4m
Non-Current Liabilities 8m
Other Non-Current Liabilities 8m
Efficiency

Free Cash Flow Analysis
Inovio Pharmaceuticals Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Inovio Pharmaceuticals Inc

Revenue
182.3k USD
Operating Expenses
-95.7m USD
Operating Income
-95.5m USD
Other Expenses
7.9m USD
Net Income
-87.6m USD
Fundamental Scores

INO Profitability Score
Profitability Due Diligence

Inovio Pharmaceuticals Inc's profitability score is 11/100. The higher the profitability score, the more profitable the company is.

11/100
Profitability
Score

Inovio Pharmaceuticals Inc's profitability score is 11/100. The higher the profitability score, the more profitable the company is.

INO Solvency Score
Solvency Due Diligence

Inovio Pharmaceuticals Inc's solvency score is 39/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Short-Term Solvency
Low Altman Z-Score
39/100
Solvency
Score

Inovio Pharmaceuticals Inc's solvency score is 39/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

INO Price Targets Summary
Inovio Pharmaceuticals Inc

Wall Street analysts forecast INO stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for INO is 7.79 USD with a low forecast of 1.82 USD and a high forecast of 13.65 USD.

Lowest
Price Target
1.82 USD
20% Downside
Average
Price Target
7.79 USD
243% Upside
Highest
Price Target
13.65 USD
501% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for INO is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

INO Insider Trading
Buy and sell transactions by insiders

INO News

Other Videos
What is the Intrinsic Value of one INO stock?

The intrinsic value of one INO stock under the Base Case scenario is 10.14 USD.

Is INO stock undervalued or overvalued?

Compared to the current market price of 2.27 USD, Inovio Pharmaceuticals Inc is Undervalued by 78%.

Back to Top